{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:57:01Z","timestamp":1785254221519,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.abd.2021.10.002","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T09:14:00Z","timestamp":1653642840000},"page":"471-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Stem cell therapy as a potential treatment option for psoriasis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6499-4062","authenticated-orcid":false,"given":"Piyu Parth","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.10.002_bib0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","article-title":"Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems","volume":"25","author":"Rapalli","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.abd.2021.10.002_bib0010","first-page":"S2","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jid.2017.09.044","article-title":"Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)","volume":"138","author":"Iskandar","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/236060","article-title":"Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis","volume":"2014","author":"Cordiali-Fei","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.abd.2021.10.002_bib0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09650.x","article-title":"Infliximab therapy induces increased polyclonality of CD4+ CD25+ regulatory T cells in psoriasis","volume":"162","author":"Diluvio","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor blockade exacerbates murine psoriasis like disease by enhancing Th17 function and decreasing expansion of Treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum Off J Am Coll Rheumatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-015-0092-3","article-title":"A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis","volume":"6","author":"Campa","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.abd.2021.10.002_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.abd.2021.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.aau2688","article-title":"T reg cells \u2012 the next frontier of cell therapy","volume":"362","author":"Bluestone","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.abd.2021.10.002_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocit.2014.12.001","article-title":"Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases","volume":"2","author":"Zhao","year":"2016","journal-title":"J Cell Immunother"},{"key":"10.1016\/j.abd.2021.10.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4541797","article-title":"Mesenchymal Stromal Cells from the Epidermis and Dermis of Psoriasis Patients: Morphology, Immunophenotype, Differentiation Patterns, and Regulation of T Cell Proliferation","volume":"2019","author":"Castro-Manrreza","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.abd.2021.10.002_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1684\/ejd.2018.3483","article-title":"Characterisation of the circular RNA landscape in mesenchymal stem cells from psoriatic skin lesions","volume":"29","author":"Liu","year":"2019","journal-title":"Eur J Dermatology"},{"key":"10.1016\/j.abd.2021.10.002_bib0075","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.4238\/2015.December.21.49","article-title":"Research Note Mesenchymal stem cells from skin lesions of psoriasis patients promote proliferation and inhibit apoptosis of HaCaT cells","volume":"14","author":"Liu","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.abd.2021.10.002_bib0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/exd.13139","article-title":"TNF inhibitors reduce the pathological Th1-Th17\/Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients","volume":"26","author":"Campanati","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0085","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3390\/ijms18102182","article-title":"Stem cells as potential candidates for psoriasis cell-replacement therapy","volume":"18","author":"Owczarczyk-Saczonek","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2021.10.002_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrep.2016.10.002","article-title":"Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice","volume":"9","author":"Lee","year":"2017","journal-title":"Biochem Biophys reports"},{"key":"10.1016\/j.abd.2021.10.002_bib0095","doi-asserted-by":"crossref","first-page":"e1022","DOI":"10.1002\/term.2423","article-title":"Tonsil derived mesenchymal stem cells (T MSCs) prevent Th17 mediated autoimmune response via regulation of the programmed death 1\/programmed death ligand 1 (PD 1\/PD L1) pathway","volume":"12","author":"Kim","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.abd.2021.10.002_bib0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.13141","article-title":"Indirect co cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells","volume":"193","author":"Campanati","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.abd.2021.10.002_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13770-018-0165-3","article-title":"Human embryonic stem cells-derived mesenchymal stem cells reduce the symptom of psoriasis in imiquimod-induced skin model","volume":"16","author":"Kim","year":"2019","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.abd.2021.10.002_bib0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.14768","article-title":"Human amnion derived mesenchymal stem cells ameliorate imiquimod induced psoriasiform dermatitis in mice","volume":"46","author":"Imai","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs)","volume":"2019","author":"Chen","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.abd.2021.10.002_bib0120","article-title":"Successful Treatment of Plaque Psoriasis with Allogeneic Gingival Mesenchymal Stem Cells: A Case Study","volume":"2020","author":"Wang","year":"2020","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.abd.2021.10.002_bib0125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/exd.14353","article-title":"The effects of human dermal\u2013derived mesenchymal stem cells on the keratinocyte proliferation and apoptosis in psoriasis","volume":"30","author":"Chang","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.abd.2021.10.002_bib0135","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bmt.1702703","article-title":"Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy","volume":"26","author":"Adkins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.abd.2021.10.002_bib0145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.2005.039479","article-title":"Amelioration\u00a0 of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation","volume":"65","author":"Woods","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.abd.2021.10.002_bib0150","unstructured":"Zurita G, Geffner L, Maldonado B, Uraga E, Armijos L. Autologous Stem Cells Implants in Psoriasis. Published online 2017."},{"key":"10.1016\/j.abd.2021.10.002_bib0155","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1038\/bcj.2015.15","article-title":"Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion","volume":"5","author":"Li","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.abd.2021.10.002_bib0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2012.08.021","article-title":"Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation","volume":"68","author":"Kaffenberger","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bmt.1700789","article-title":"Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation","volume":"19","author":"Kishimoto","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.abd.2021.10.002_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10169","article-title":"Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature","volume":"71","author":"Kanamori","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.abd.2021.10.002_bib0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2003.010702","article-title":"Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance","volume":"63","author":"Mohren","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.abd.2021.10.002_bib0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bmt.1703874","article-title":"High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-\u2019Hodgkin\u2019s lymphoma","volume":"31","author":"Rossi","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.abd.2021.10.002_bib0190","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1200\/JCO.2008.17.6560","article-title":"Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma","volume":"26","author":"Braiteh","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.abd.2021.10.002_bib0195","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/bmt.2012.68","article-title":"Complete resolution of guttate psoriasis following autologous SCT for\u2019 Ewing\u2019s sarcoma in a pediatric patient","volume":"47","author":"Held","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.abd.2021.10.002_bib0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.12026","article-title":"Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation","volume":"159","author":"Mori","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.abd.2021.10.002_bib0205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013589","article-title":"Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.abd.2021.10.002_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103137","article-title":"Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation","volume":"60","author":"Ugur","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.abd.2021.10.002_bib0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2133.2010.09790.x","article-title":"Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis","volume":"163","author":"Zhang","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0220","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.300.6729.908","article-title":"Clearance of severe psoriasis after allogenic bone marrow transplantation","volume":"300","author":"Eedy","year":"1990","journal-title":"BMJ."},{"key":"10.1016\/j.abd.2021.10.002_bib0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2133.1997.17821869.x","article-title":"Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity","volume":"137","author":"Snowden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.002_bib0230","first-page":"E7","article-title":"Remission of psoriasis 13 years after autologous stem cell transplant","volume":"95","author":"Sung","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.abd.2021.10.002_bib0235","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs)","volume":"2019","author":"Chen","year":"2019","journal-title":"Stem Cells Int"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:41:16Z","timestamp":1759794076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0365059622000770"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.10.002","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapy as a potential treatment option for psoriasis","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}